- Publicações
- Pesquisar
- Estatísticas
Ovarian Cancer Pathology Characteristics as Predictors of Variant Pathogenicity in Brca1 and Brca2
AuthID
P-00Y-9WT
P-00Y-9WT
99
Author(s)
O’Mahony, DG
·Ramus, SJ
·Southey, MC
·Meagher, NS
·Hadjisavvas, A
·John, EM
·Hamann, U
·Imyanitov, EN
·Andrulis, IL
·Sharma, P
·[+76]·
[+3]·
la Hoya, M
·van Overeem Hansen, T
·dos Santos, ES
·HEBON Investigators
·GEMO Study Collaborators
·AOCS Group
·CZECANCA Consortium
·The Consortium of Investigators of Modifiers of BRCA1/2
·Evidence based Network for the Interpretation of Germline Mutant Alleles Consortium
Tipo de Documento
Article
Year published
2023
Publicado
in British Journal of Cancer, ISSN: 0007-0920
Volume: 128, Número: 12, Páginas: 2283-2294
Indexing
Publication Identifiers
Source Identifiers
ISSN: 0007-0920
Export Publication Metadata
Publication Export Settings
Lista Marked
Citações
Oops! It looks like you don't have access to this content.
This section is restricted to uses with b-on access.
CORE Conference
No information about CORE Rank
During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.
TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.
Journal Factors
Oops! It looks like you don't have access to this content.
This section is restricted to uses with b-on access.
Full Text
| Name Order | Nome | Name Order | Nome | Name Order | Nome | ||
|---|---|---|---|---|---|---|---|
| 1 | O’Mahony, DG; | 2 | Ramus, SJ; | 3 | Southey, MC; | ||
| 4 | Meagher, NS; | 5 | Hadjisavvas, A; | 6 | John, EM; | ||
| 7 | Hamann, U; | 8 | Imyanitov, EN; | 9 | Andrulis, IL; | ||
| 10 | Sharma, P; | 11 | Daly, MB; | 12 | Hake, CR; | ||
| 13 | Weitzel, JN; | 14 | Jakubowska, A; | 15 | Godwin, AK; | ||
| 16 | Arason, A; | 17 | Bane, A; | 18 | Simard, J; | ||
| 19 | Soucy, P; | 20 | Caligo, MA; | 21 | Mai, PL; | ||
| 22 | Claes, KBM; | 23 | Teixeira, MR; | 24 | Chung, WK; | ||
| 25 | Lazaro, C; | 26 | Hulick, PJ; | 27 | Toland, AE; | ||
| 28 | Pedersen, IS; | 29 | Mourits, MJE; | 30 | Neuhausen, SL; | ||
| 31 | Vega, A; | 32 | la Hoya, M; | 33 | Nevanlinna, H; | ||
| 34 | Dhawan, M; | 35 | Zampiga, V; | 36 | Danesi, R; | ||
| 37 | Varesco, L; | 38 | Gismondi, V; | 39 | Vellone, VG; | ||
| 40 | James, PA; | 41 | Janavicius, R; | 42 | Nikitina Zake, L; | ||
| 43 | Nielsen, FC; | 44 | van Overeem Hansen, T; | 45 | Pejovic, T; | ||
| 46 | Borg, A; | 47 | Rantala, J; | 48 | Offit, K; | ||
| 49 | Montagna, M; | 50 | Nathanson, KL; | 51 | Domchek, SM; | ||
| 52 | Osorio, A; | 53 | García, MJ; | 54 | Karlan, BY; | ||
| 55 | Lesueur, F; | 56 | De Fazio, A; | 57 | Bowtell, D; | ||
| 58 | De Fazio, A; | 59 | McGuffog, L; | 60 | Leslie, G; | ||
| 61 | Parsons, MT; | 62 | Dörk, T; | 63 | Speith, LM; | ||
| 64 | dos Santos, ES; | 65 | da Costa, AABA; | 66 | Radice, P; | ||
| 67 | Peterlongo, P; | 68 | Papi, L; | 69 | Engel, C; | ||
| 70 | Hahnen, E; | 71 | Schmutzler, RK; | 72 | Wappenschmidt, B; | ||
| 73 | Easton, DF; | 74 | Tischkowitz, M; | 75 | Singer, CF; | ||
| 76 | Tan, YY; | 77 | Whittemore, AS; | 78 | Sieh, W; | ||
| 79 | Brenton, JD; | 80 | Yannoukakos, D; | 81 | Fostira, F; | ||
| 82 | Konstantopoulou, I; | 83 | Soukupova, J; | 84 | Vocka, M; | ||
| 85 | Chenevix Trench, G; | 86 | Pharoah, PDP; | 87 | Antoniou, AC ; | ||
| 88 | Goldgar, DE; | 89 | Spurdle, AB; | 90 | Michailidou, K; | ||
| 91 | la Hoya, M; | 92 | van Overeem Hansen, T; | 93 | dos Santos, ES; | ||
| 94 | HEBON Investigators; | 95 | GEMO Study Collaborators; | 96 | AOCS Group; | ||
| 97 | CZECANCA Consortium; | 98 | The Consortium of Investigators of Modifiers of BRCA1/2; | 99 | Evidence based Network for the Interpretation of Germline Mutant Alleles Consortium; |
